Associated Papers
KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer.
Sheng H et al.
Oncogene, 2025
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S5
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Alcaniz J et al.
Frontiers in Oncology, 2023
37114125 (PubMed )
Supplement: Table_1.xlsx › Mutations
Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy.
von Baumgarten L et al.
Theranostics, 2020
31903155 (PubMed )
Supplement: thnov10p0856s1.pdf
Modification of Akt by SUMO conjugation regulates alternative splicing and cell cycle.
Risso G et al.
Cell Cycle (georgetown, Tex.), 2013
Select a paper to view details